Auxological evaluation and determinants of growth failure at the time of adoption in Eastern European adoptees

J Pediatr Endocrinol Metab. 2009 Jan;22(1):31-9. doi: 10.1515/jpem.2009.22.1.31.

Abstract

Aim: To identify factors contributing to growth failure in international adoptees (IAs) from Eastern Europe.

Study design: 138 IAs from Eastern Europe, 6-59 months old, were evaluated within 3 weeks of US arrival. Complete history, anthropometry, and serum for growth factors were obtained. Facial features were examined for risk of prenatal alcohol exposure.

Results: Upon arrival, mean height (-1.23 +/- 1.07), weight (-1.43 +/- 1.29), and occipitofrontal circumference (OFC) (-0.63 +/- 1.10) SDS in IAs were significantly less than population means for US children. In a multiple regression model, age, low birth weight (LBW), insulin-like growth factor binding protein-3, and high risk for fetal alcohol syndrome were independent predictors of height SDS. LBW also independently predicted lower weight SDS and smaller OFC SDS.

Conclusions: We recommend that IAs undergo screening upon US arrival to identify risk factors for poor growth, particularly evidence of LBW and fetal alcohol exposure. Catch-up growth should be monitored in all children following adoption.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adoption*
  • Body Weights and Measures
  • Child Development / physiology*
  • Child, Preschool
  • Europe, Eastern
  • Female
  • Growth Disorders / blood
  • Growth Disorders / diagnosis*
  • Growth Disorders / epidemiology
  • Growth Disorders / etiology
  • Humans
  • Infant
  • Insulin-Like Growth Factor Binding Protein 3
  • Insulin-Like Growth Factor Binding Proteins / blood
  • Insulin-Like Growth Factor I / analysis
  • Longitudinal Studies
  • Male
  • Risk Factors
  • Time Factors
  • United States

Substances

  • IGFBP3 protein, human
  • Insulin-Like Growth Factor Binding Protein 3
  • Insulin-Like Growth Factor Binding Proteins
  • Insulin-Like Growth Factor I